Shamir Geller

Shamir Geller, MD

Areas of Expertise

Conditions I Treat

  • Mycosis fungoides (MF)
  • B-cell skin lymphomas
  • T-cell skin lymphomas

My Specialties

  • Diagnosis and management of skin cancer
  • Oncodermatology
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
English
Share

Get to Know Me

I am a dermatologist who specializes in caring for patients with cutaneous (skin) lymphoma. I also have expertise in the diagnosis and treatment of basal cell carcinoma, squamous cell carcinoma, and early-stage melanoma, as well as other rare forms of skin cancer.

During my fellowship training in cutaneous oncology at Memorial Sloan Kettering Cancer Center (MSK), I developed my interest and experience in managing cutaneous T-cell lymphoma (including mycosis fungoides and other subtypes) and B-cell lymphomas of the skin.

Read more

In my clinic, I have the privilege of partnering with medical oncologists, pathologists, radiation oncologists, and other experts to provide our patients with comprehensive care. We effectively address their symptoms and pay close attention to their comfort, personal preferences, and quality of life. In addition to providing the best possible care, we offer promising novel therapies in clinical trials at MSK.

My research efforts study the incidence and prognosis of skin lymphoma in specific populations (ethnic, and elderly, and pediatric groups), as well as its association with other medical conditions and therapies. I am constantly looking for new ways to enhance how we diagnose cutaneous lymphoma. This includes understanding new prognostic factors (aspects that give us a sense of a patient’s outcome) that may be useful in patient care.

I am firmly committed to education by tutoring the next generation of dermatologists at MSK and by sharing my knowledge and experience with colleagues outside of MSK. I enjoy teaching and mentoring fellows, residents, and students in the clinic and in research projects. I have served as an invited speaker at national and international dermatology meetings, and I am also the author of numerous peer-reviewed journal articles.
Outside of work, I enjoy spending time with my wife, three kids, and my dog. I like to travel, cook, and go camping.

What I Do at MSK

I'm a dermatologist, which is a doctor with special training in skin, hair, and nails.

  • Associate Attending Physician
Areas of Expertise

Conditions I Treat

  • Mycosis fungoides (MF)
  • B-cell skin lymphomas
  • T-cell skin lymphomas

My Specialties

  • Diagnosis and management of skin cancer
  • Oncodermatology
Education & Honors

Education

  • MD, Tel Aviv University

Residencies

  • Dermatology, Tel Aviv Sourasky Medical Center

Fellowships

  • Cutaneous Oncology, Memorial Sloan Kettering Cancer Center

Board Certifications

  • Dermatology and Venereology (Israel Ministry of Health)

Awards and Honors

  • Young Investigator Award, Cutaneous Lymphoma Foundation (2019)

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients
Request an appointment by logging in to MSK MyChart or calling your Care Team. If you are not enrolled in MSK MyChart, ask your Care Team to send you an invitation. You can also go to MSK MyChart and select “Sign up now.”

Contact and Location

Dr. Geller sees patients at one location.

Location
New York, NY

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Dermatology Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Geller S, Lebowitz E, Pulitzer MP, Horwitz SM, Moskowitz AJ, Dusza S, Myskowski PL. Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center. J Am Acad Dermatol. 2020 Aug;83(2):430-439. doi: 10.1016/j.jaad.2019.08.073. Epub 2019 Sep 6. PubMed PMID: 31499157; PubMed Central PMCID: PMC7058509.

Lebowitz E, Geller S, Flores E, Pulitzer M, Horwitz S, Moskowitz A, Kheterpal M, Myskowski PL. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients. J Eur Acad Dermatol Venereol. 2019 Jan;33(1):108-114. doi: 10.1111/jdv.15236. Epub 2018 Sep 25. PubMed PMID: 30176169; PubMed Central PMCID: PMC6338490.

Read more

Bomze D, Sprecher E, Goldberg I, Samuelov L, Geller S. Primary Cutaneous B-Cell Lymphomas in Children and Adolescents: A SEER Population-Based Study. Clin Lymphoma Myeloma Leuk. 2021 Dec;21(12):e1000-e1005. doi: 10.1016/j.clml.2021.07.021. Epub 2021 Jul 25. PubMed PMID: 34417159.

Pulitzer M, Geller S, Kumar E, Frosina D, Moskowitz A, Horwitz S, Myskowski P, Kheterpal M, Chan A, Dogan A, Jungbluth A. T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders. Histopathology. 2018 Oct;73(4):653-662. doi: 10.1111/his.13671. Epub 2018 Jul 27. PubMed PMID: 29893430; PubMed Central PMCID: PMC6153041.

Geller S, Gomez CJ, Myskowski PL, Pulitzer M. Follicular mucinosis in patients with hematologic malignancies other than mycosis fungoides: A clinicopathologic study. J Am Acad Dermatol. 2019 Jun;80(6):1704-1711. doi: 10.1016/j.jaad.2019.01.062. Epub 2019 Feb 1. Review. PubMed PMID: 30716405; PubMed Central PMCID: PMC6526060.

View a list of Dr. Geller’s publications.

Publications on PubMed

Visit PubMed for a full listing of Dr. Geller’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Shamir Geller discloses the following relationships and financial interests:

  • RAFA Laboratories Ltd
    Professional Services and Activities
  • Takeda Pharmaceuticals
    Professional Services and Activities
  • UptoDate
    Intellectual Property Rights

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures